Affiliation: Memorial Sloan-Kettering Cancer Center
- The indication for postchemotherapy lymph node dissection in clinical stage IS nonseminomatous germ cell tumorAtreya Dash
Department of Urology and Genitourinary Oncology Service, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
Cancer 112:800-5. 2008..The objectives of the current study were to determine the clinical outcome, patterns of relapse, and incidence of teratoma in the retroperitoneum for men with cIS NSGCT...
- Comparison of outcomes in elective partial vs radical nephrectomy for clear cell renal cell carcinoma of 4-7 cmAtreya Dash
Department of Urology, Memorial Sloan Kettering Cancer Center, New York, NY, USA
BJU Int 97:939-45. 2006..To compare the outcomes of patients who had a elective partial nephrectomy (PN) or radical nephrectomy (RN) for clear cell renal cell carcinoma (RCC) of 4-7 cm...
- Comorbidity and competing risks for mortality in men with prostate cancerTimothy J Daskivich
Department of Urology, David Geffen School of Medicine, University of California, Los Angeles, USA
Cancer 117:4642-50. 2011..The authors sought to assess the competing risks of nonprostate cancer and prostate cancer mortality among men with differing Charlson comorbidity index scores and tumor risks...
- A role for neoadjuvant gemcitabine plus cisplatin in muscle-invasive urothelial carcinoma of the bladder: a retrospective experienceAtreya Dash
Division of Urology, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
Cancer 113:2471-7. 2008..Gemcitabine plus cisplatin (GC) has similar efficacy and less toxicity than MVAC in metastatic disease, but is untested as neoadjuvant treatment...
- Consideration of comorbidity in risk stratification prior to prostate biopsyMichael A Liss
Department of Urology, University of California at Irvine, Irvine, California, USA
Cancer 119:2413-8. 2013..In the current study, the authors used these assessments to determine comorbidity and prognosis before prostate biopsy and the subsequent diagnosis of prostate cancer to identify those patients least likely to benefit from treatment...
- Improved prediction of long-term, other cause mortality in men with prostate cancerTimothy J Daskivich
Department of Urology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California 90095 1738, USA
J Urol 186:1868-73. 2011..We identified long-term risks of other cause mortality associated with comorbidities in the Charlson index and applied these to the creation of a prostate cancer specific comorbidity index...
- Copy number and gene expression differences between African American and Caucasian American prostate cancerAmy E Rose
Department of Urology, New York University School of Medicine, New York, New York 10016, USA
J Transl Med 8:70. 2010....
- Intermediate followup of hand assisted laparoscopic nephroureterectomy for urothelial carcinoma: factors associated with outcomesJ Stuart Wolf
Department of Urology, University of Michigan, Ann Arbor, USA
J Urol 173:1102-7. 2005..We report our experience with hand assisted laparoscopic (HALS) nephroureterectomy and describe the associations of preoperative, operative and pathological factors with outcome...
- Patient, surgeon, and treatment characteristics associated with homologous blood transfusion requirement during radical retropubic prostatectomy: multivariate nomogram to assist patient counselingAtreya Dash
Department of Urology, University of Michigan School of Medicine, Ann Arbor, Michigan, USA
Urology 64:117-22. 2004..Homologous blood transfusion is sometimes required during or after RRP, but predictive models for estimating transfusion probability using patient and surgical characteristics are lacking...
- Screening rectal culture to identify fluoroquinolone-resistant organisms before transrectal prostate biopsy: do the culture results between office visit and biopsy correlate?Michael A Liss
Department of Urology, University of California, Irvine, CA, USA
Urology 82:67-71. 2013..To investigate the performance of screening rectal cultures obtained 2 weeks before transrectal prostate biopsy to detect fluoroquinolone-resistant organisms and again at transrectal prostate biopsy...
- Impact of socioeconomic factors on prostate cancer outcomes in black patients treated with surgeryAtreya Dash
Division of Urology, Memorial Sloan Kettering Cancer Center, New York, New York, USA
Urology 72:641-6. 2008..To determine whether socioeconomic factors affect prostate cancer outcomes, we studied a cohort of only black patients to minimize known confounding factors...
- Endockscope: using mobile technology to create global point of service endoscopyWilliam Sohn
Department of Urology, University of California, Irvine, Orange, California 92862, USA
J Endourol 27:1154-60. 2013..We present our initial experience with Endockscope, a new docking system that optimizes the coupling of the iPhone 4S with modern endoscopes...
- Percutaneous treatment of renal cystic nephromaAtreya Dash
Department of Urology, University of Michigan, Ann Arbor, Michigan 48109, USA
J Endourol 19:724-5. 2005..When its presence is suspected preoperatively, nephron-sparing surgery can be applied. We describe treatment of a cystic nephroma that is the first reported, to our knowledge, using endoscopic techniques...
- Overtreatment of men with low-risk prostate cancer and significant comorbidityTimothy J Daskivich
Department of Urology, David Geffen School of Medicine, University of California, Los Angeles, California, USA
Cancer 117:2058-66. 2011..Men with low-risk prostate cancer and significant comorbidity are susceptible to overtreatment. The authors sought to compare the impact of comorbidity and age on treatment choice in men with low-risk disease...
- Failure of percutaneous endoscopic resection of a renal cystic nephroma on longer-term follow-upJ Stuart Wolf
University of Michigan, Department of Urology, Ann Arbor, Michigan 48109 0330, USA
J Endourol 22:1505-7. 2008..Laparoscopic radical nephrectomy without adrenalectomy revealed benign cystic nephroma...
- Integrative analysis of genomic aberrations associated with prostate cancer progressionJung H Kim
Michigan Center for Translational Pathology, Department of Pathology, Department of Urology, Program of Bioinformatics, and Comprehensive Cancer Center, University of Michigan Medical School, Ann Arbor, MI 48109 0940, USA
Cancer Res 67:8229-39. 2007..Integrative analysis with matched mRNA profiles identified genetic alterations in several proposed candidate genes implicated in prostate cancer progression...
- A case of Castleman's disease that presented as a retroperitoneal massKinjal Vora
Department of Surgery, Division of Urology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Nat Clin Pract Urol 4:285-8. 2007..There were no aggravating or relieving factors for the left-flank pain and no other presenting symptoms, and the physical examination was unremarkable...
- Impact of renal impairment on eligibility for adjuvant cisplatin-based chemotherapy in patients with urothelial carcinoma of the bladderAtreya Dash
Department of Urology, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
Cancer 107:506-13. 2006..Renal impairment may be a major factor limiting its use. The current study was designed to determine the proportion of patients ineligible to receive adjuvant cisplatin-based chemotherapy based on inadequate renal function alone...
- Changes in differential gene expression because of warm ischemia time of radical prostatectomy specimensAtreya Dash
Department of Urology, University of Michigan, Ann Arbor, USA
Am J Pathol 161:1743-8. 2002....
- Holmium laser fulguration of superficial urothelial carcinoma of the pendulous urethraMichael A Liss
Department of Urology, University of California Irvine and Long Beach Veterans Affairs Medical Center, Orange, CA, USA
Indian J Urol 28:427-9. 2012..The surgical approach was staged and provided excellent long term results for management of superficial UC...
- Prevalence and significance of fluoroquinolone resistant Escherichia coli in patients undergoing transrectal ultrasound guided prostate needle biopsyMichael A Liss
Department of Urology, University of California Irvine, Irvine, California, USA
J Urol 185:1283-8. 2011..We estimated the prevalence of fluoroquinolone resistant Escherichia coli in patients undergoing repeat transrectal ultrasound guided prostate needle biopsy and identified high risk groups...
- Prostate cancer involving the bladder neck: recurrence-free survival and implications for AJCC staging modification. American Joint Committee on CancerAtreya Dash
Department of Urology, University of Michigan School of Medicine, Ann Arbor, Michigan 48109, USA
Urology 60:276-80. 2002..We therefore compared the recurrence risk in cases with bladder neck involvement with that of cases with extraprostatic extension and/or seminal vesicle invasion...